The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/792774
CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2017 CMO LEADERSHIP AWARDS WINNERS 48 LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 QUALITY Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging SERVICES & CAPABILITIES: aseptic fill/finish, cap- sules, controlled substances, creams & ointments, cytotoxic & high potency compounds, gels, inject- ables, liquids, non-sterile, OTC, parenterals (large & small volume), proteins, semisolids, soft gels, solid dose, sustained release, syringes: prefilled, hot melt extrusion, bioavailability enhancement techs, modified & targeted release, bi-layer tablets, liquid- fill hard capsule techs, controlled substances, pro- teins, mammalian cell culture syringes (prefilled) "Our team is committed to producing the highest quality support and services for our partners, and this award demonstrates the consistency necessary for great customer service in the areas of capabilities, compatibility, expertise, quality, reliability and discovery. We are extremely proud of this accomplishment and the remarkable impact we help make for patients around the world." DRUG TYPE: Pharmaceuticals, Biopharmaceuticals AZITA SALEKI-GERHARDT, PH.D. SVP Operations CATEGORIES WON: AbbVie North Chicago, IL www.abbviecontractmfg.com Phone: +1 847 938 8524 Contact: Michelle Calhoun Email: michelle.calhoun@abbvie.com Key locations: Ludwigshafen, Germany; Sligo & Cork, Ireland; Campoverde, Italy; Barceloneta, Puerto Rico; Worcester, MA and Lake County, IL, USA INDIVIDUAL ATTRIBUTE AWARDS: cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre-Clinical, Clinical (Phase 1, Phase 2) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: capsules, controlled substances, creams & ointments, cytotoxic & high potency compounds, gels, generics, injectables, liquids, non-sterile, powders: non-sterile, solid dose, sustained release, topicals, continuous manufacturing, serialization & aggregation "As a leading CDMO for APIs and finished dosage forms, we take pride in our ability to partner with our pharmaceutical customers to provide a quality and reliable service that is backed by a team of world-class scientific experts. Being recognized in these CMO Leadership Awards for our quality, capabilities, and expertise is a true testament to our people, culture and service/abilities." DRUG TYPE: Pharmaceuticals IAN MUIR, PH.D. Managing Director CATEGORIES WON: Aesica Pharmaceuticals Newcastle Upon Tyne, UK www.aesica-pharma.com Phone: +44 (0)191 293 1460 Contact: Mark Hammond Email: mark.hammond@aesica-pharma.com Key locations: Cramlington, UK; Queenborough, UK; Monheim, UK; Zwickau, Germany; Pianezza, Italy INDIVIDUAL ATTRIBUTE AWARDS: right first time DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production SERVICES & CAPABILITIES: creams & ointments, generics, injectables, liquids, non-sterile, ophthalmics, OTC, parenterals: large volume, powders: non-sterile, proteins, semisolids, soft gels, solid dose, solutions & suspensions, topicals, vaccines "Albemarle Corporation's Fine Chemistry Services business is excited and honored to receive the CMO Leadership Awards. These awards are validation of over thirty years of tireless efforts, dedicated to custom manufacturing. Through teamwork and a customer focus, we have established world-class facilities where we can support bench to commercial processing at one site and enable customers to take Registered Starting Materials to final Active Pharmaceutical Ingredients with one US manufacturer." DRUG TYPE: Pharmaceuticals SCOTT MARTIN President - Fine Chemistry Services CATEGORIES WON: Albemarle Corporation Charlotte, NC www.albemarle.com/FCS Phone: +1 980 299 5700 Contact: Julie Risdon Email: julie.risdon@albemarle.com Key locations: South Haven, MI; Tyrone, PA; Pasadena, TX INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science